MPA-ABS Renews AI Driven Decarbonization Research Partnership
Singapore’s MPA has signed a MoU with ABS to renew its partnership in maritime research, development and innovation.
Both parties will also work together to develop the next-generation maritime workforce in Singapore, by...
Hunter Group Announces Its $168.4m Vessels Sale Deal
Hunter Tankers AS, a wholly owned subsidiary of Hunter Group ASA has signed a MoA for the sale of Hunter Saga and Hunter Laga, says a press release published on their website.
What is in...
LNG- Hydrogen the ‘Frontrunner Fuels’ for Low-Carbon Shipping
Apart from the ambitious target of the 2020 Global Sulphur Cap set by the IMO, shipowners and operators must also take into considerations the GHG targets for 2030 and the emissions goals for...
Weekly Bulk Report – Week 44, 2020
The Baltic Briefing has released a report about the dry bulk market for the 44th week of shipping activities of this year. The report dated 30th October highlights the plight of the dry bulk...
Regional Regulations Cripple IMO’s Decarbonisation Goal
Ship owners and operators want International shipping stakeholders to collaborate through IMO to support its decarbonisation effort and avoid regional regulations, says an article published in Riviera Maritime Media.
Regional regulations
One of the main concerns...
Weekly Tanker Report – Week 44, 2020
The Baltic Briefing has issued the tanker report for the 44th week of this year. The report dated 30th October 2020 provides a valuable insight into this week’s tanker market dealings, freight rates, and charter...
Royal Caribbean Group Files 4 New Trademark Names
Royal Caribbean Group filed 4 trademarks with the US Patent and Trademark Office, says an article published on their website.
New trademarks
Royal Caribbean Group's legal team has filed a variety of new trademarks that sound...
Europe Second COVID Wave Cases Surpass 10 Million, Doubles in 5 Weeks
Europe's COVID-19 cases double in five weeks and total infections surpass 10 million, reports Reuters.
10 million total infections
According to a Reuters tally, Europe’s new COVID-19 cases have doubled in five weeks, propelling the region...
The Dubious Case of Remdesivir, The First FDA Approved COVID Drug
Within weeks of Remdesivir trial data publishing, GiLead signed a EU manufacturing deal and got the drug approved by FDA.
The dubious circumstances of the first FDA approved covid drug shows how the...
Scientists Question FDA Remdesivir Approval
Scientists have questioned FDA's emergency authorization of GiLead's Remdesivir overlooking critical data and evidence.
Many have questioned how the company has undermined WHO's Solidarity trial.
The absence of viral load data in FDA's...